Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma

BACKGROUND: Although checkpoint blockades have become widely used, the immunological impact in cancer patients, especially those with oral cavity squamous cell carcinoma (OCSCC), has not been well studied. METHODS: The present study assessed the immunological impact of anti-PD-1 (nivolumab) treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Ying, Neskey, David M., Horton, Joshua D., Paulos, Chrystal M., Knochelmann, Hannah M., Armeson, Kent E., Young, M. Rita I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076935/
https://www.ncbi.nlm.nih.gov/pubmed/32183719
http://dx.doi.org/10.1186/s12885-020-06726-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076935/
https://www.ncbi.nlm.nih.gov/pubmed/32183719
http://dx.doi.org/10.1186/s12885-020-06726-3

Ejemplares similares